Abstract

Lung cancer and chronic lung diseases impose major disease burdens worldwide and are caused by inhaled noxious agents including tobacco smoke. The cellular origins of environmental-induced lung tumors and of the dysfunctional airway and alveolar epithelial turnover observed with chronic lung diseases are unknown. To address this, we combined mouse models of genetic labeling and ablation of airway (club) and alveolar cells with exposure to environmental noxious and carcinogenic agents. Club cells are shown to survive KRAS mutations and to form lung tumors after tobacco carcinogen exposure. Increasing numbers of club cells are found in the alveoli with aging and after lung injury, but go undetected since they express alveolar proteins. Ablation of club cells prevents chemical lung tumors and causes alveolar destruction in adult mice. Hence club cells are important in alveolar maintenance and carcinogenesis and may be a therapeutic target against premalignancy and chronic lung disease.

Data availability

All raw data produced in this study are provided as *.xlsx source data Supplements. The microarray data produced by this study were deposited at GEO (http://www.ncbi.nlm.nih.gov/geo/; Accession ID: GSE94981). Previously reported [36-40] murine ATII and human AEC, ATII, AMΦ, non-smokers lung, and LUAD microarray data are available at GEO using Accession IDs GSE82154, GSE55459, GSE46749, GSE18816, and GSE43458).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Magda Spella

    Department of Physiology, University of Patras, Rio, Greece
    For correspondence
    magsp@upatras.gr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2505-7778
  2. Ioannis Lilis

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  3. Mario AA Pepe

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Yuanyuan Chen

    Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Maria Armaka

    Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
    Competing interests
    The authors declare that no competing interests exist.
  6. Anne-Sophie Lamort

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Dimitra E Zazara

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  8. Fani Roumelioti

    Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
    Competing interests
    The authors declare that no competing interests exist.
  9. Malamati Vreka

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  10. Nikolaos I Kanellakis

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  11. Darcy E Wagner

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Anastasios D Giannou

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  13. Vasileios Armenis

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  14. Kristina AM Arendt

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Laura V Klotz

    Comprehensive Pneumology Center (CPC), Helmholtz Center Munich, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Dimitrios Toumpanakis

    1st Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
  17. Vassiliki Karavana

    1st Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
  18. Spyros G Zakynthinos

    1st Department of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital, Athens, Greece
    Competing interests
    The authors declare that no competing interests exist.
  19. Ioanna Giopanou

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  20. Antonia Marazioti

    Department of Physiology, University of Patras, Rio, Greece
    Competing interests
    The authors declare that no competing interests exist.
  21. Vassilis Aidinis

    Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece
    Competing interests
    The authors declare that no competing interests exist.
  22. Rocio Sotillo

    Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0855-7917
  23. Georgios T Stathopoulos

    Department of Physiology, University of Patras, Rio, Greece
    For correspondence
    gstathop@upatras.gr
    Competing interests
    The authors declare that no competing interests exist.

Funding

H2020 European Research Council (260524)

  • Georgios T Stathopoulos

Hellenic State Scholarship Foundation (Post-doctoral Research Fellowship)

  • Magda Spella

Howard Hughes Medical Institute (International Research Scholars Award)

  • Rocio Sotillo

German Center for Lung Research

  • Kristina AM Arendt
  • Laura V Klotz
  • Georgios T Stathopoulos

Hellenic Thoracic Society (PhD Fellowship)

  • Malamati Vreka
  • Anastasios D Giannou

H2020 European Research Council (281614)

  • Rocio Sotillo

H2020 European Research Council (679345)

  • Georgios T Stathopoulos

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Experiments were designed and approved a priori by the Veterinary Administration of the Prefecture of Western Greece (approval numbers 3741/16.11.2010, 60291/3035/19.03.2012, and 118018/578/30.04.2014) and were conducted according to Directive 2010/63/EU (http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1486710385917&uri=CELEX:32010L0063).

Human subjects: Archival tissue samples of patients with lung adenocarcinoma were used in this study. The observational protocol for the original studies adhered to the Helsinki Declaration and was approved by the Ethics Committee of the University Hospital of Patras, and all patients gave written informed consent.

Copyright

© 2019, Spella et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,676
    views
  • 639
    downloads
  • 47
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Magda Spella
  2. Ioannis Lilis
  3. Mario AA Pepe
  4. Yuanyuan Chen
  5. Maria Armaka
  6. Anne-Sophie Lamort
  7. Dimitra E Zazara
  8. Fani Roumelioti
  9. Malamati Vreka
  10. Nikolaos I Kanellakis
  11. Darcy E Wagner
  12. Anastasios D Giannou
  13. Vasileios Armenis
  14. Kristina AM Arendt
  15. Laura V Klotz
  16. Dimitrios Toumpanakis
  17. Vassiliki Karavana
  18. Spyros G Zakynthinos
  19. Ioanna Giopanou
  20. Antonia Marazioti
  21. Vassilis Aidinis
  22. Rocio Sotillo
  23. Georgios T Stathopoulos
(2019)
Club cells form lung adenocarcinomas and maintain the alveoli of adult mice
eLife 8:e45571.
https://doi.org/10.7554/eLife.45571

Share this article

https://doi.org/10.7554/eLife.45571

Further reading

    1. Cancer Biology
    2. Cell Biology
    Kourosh Hayatigolkhatmi, Chiara Soriani ... Simona Rodighiero
    Tools and Resources

    Understanding the cell cycle at the single-cell level is crucial for cellular biology and cancer research. While current methods using fluorescent markers have improved the study of adherent cells, non-adherent cells remain challenging. In this study, we addressed this gap by combining a specialized surface to enhance cell attachment, the FUCCI(CA)2 sensor, an automated image analysis pipeline, and a custom machine learning algorithm. This approach enabled precise measurement of cell cycle phase durations in non-adherent cells. This method was validated in acute myeloid leukemia cell lines NB4 and Kasumi-1, which have unique cell cycle characteristics, and we tested the impact of cell cycle-modulating drugs on NB4 cells. Our cell cycle analysis system, which is also compatible with adherent cells, is fully automated and freely available, providing detailed insights from hundreds of cells under various conditions. This report presents a valuable tool for advancing cancer research and drug development by enabling comprehensive, automated cell cycle analysis in both adherent and non-adherent cells.

    1. Cancer Biology
    2. Computational and Systems Biology
    Rosalyn W Sayaman, Masaru Miyano ... Mark LaBarge
    Research Article

    Effects from aging in single cells are heterogenous, whereas at the organ- and tissue-levels aging phenotypes tend to appear as stereotypical changes. The mammary epithelium is a bilayer of two major phenotypically and functionally distinct cell lineages: luminal epithelial and myoepithelial cells. Mammary luminal epithelia exhibit substantial stereotypical changes with age that merit attention because these cells are the putative cells-of-origin for breast cancers. We hypothesize that effects from aging that impinge upon maintenance of lineage fidelity increase susceptibility to cancer initiation. We generated and analyzed transcriptomes from primary luminal epithelial and myoepithelial cells from younger <30 (y)ears old and older >55y women. In addition to age-dependent directional changes in gene expression, we observed increased transcriptional variance with age that contributed to genome-wide loss of lineage fidelity. Age-dependent variant responses were common to both lineages, whereas directional changes were almost exclusively detected in luminal epithelia and involved altered regulation of chromatin and genome organizers such as SATB1. Epithelial expression of gap junction protein GJB6 increased with age, and modulation of GJB6 expression in heterochronous co-cultures revealed that it provided a communication conduit from myoepithelial cells that drove directional change in luminal cells. Age-dependent luminal transcriptomes comprised a prominent signal that could be detected in bulk tissue during aging and transition into cancers. A machine learning classifier based on luminal-specific aging distinguished normal from cancer tissue and was highly predictive of breast cancer subtype. We speculate that luminal epithelia are the ultimate site of integration of the variant responses to aging in their surrounding tissue, and that their emergent phenotype both endows cells with the ability to become cancer-cells-of-origin and represents a biosensor that presages cancer susceptibility.